Smoking is the leading cause of chronic obstructive pulmonary …
WEBNov 15, 2023 · A new brief reveals that smoking remains one of the leading causes of chronic obstructive pulmonary disease (COPD), a common lung disease that causes breathing problem and claiming the lives of over 3 million people every year.
Sanofi blockbuster drug wins clearance in US for lung disease
WEB2 days ago · The US Food and Drug Administration gave a green light to the shot as an add-on treatment for some patients with chronic obstructive pulmonary disease, Sanofi said in a statement Friday.
GOLD COPD report: 2023 update - The Lancet Respiratory Medicine
WEBOn Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).
2024 GOLD Report Reflects New Research on COPD Management
WEBDec 8, 2023 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a lead report author a...
Immune treatment tackles chronic obstructive pulmonary disease
WEBAug 16, 2023 · Chronic obstructive pulmonary disease (COPD) is a common lung disease caused by tobacco smoke and other airborne pollutants, and it can be fatal. COPD exacerbations — defined as acute...
COPD News - ScienceDaily
WEB4 days ago · Latest research news on COPD, including chronic bronchitis, chronic obstructive airway disease, chronic obstructive lung disease and emphysema.
Chronic obstructive pulmonary disease - Latest research and news
WEBSep 4, 2024 · Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue.
Dupilumab for COPD with Type 2 Inflammation Indicated by …
WEBMay 21, 2023 · In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts.
GOLD COPD report: 2024 update - The Lancet Respiratory Medicine
WEBDec 4, 2023 · The 2024 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD) has been published.
Regeneron, Sanofi's Dupixent Get FDA Approval For Chronic …
WEB2 days ago · Regeneron Pharmaceuticals, Inc. and Sanofi (), Friday announced that the U.S. Food and Drug Administration has approved Dupixent as an add-on maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease or COPD and an eosinophilic phenotype.Sanofi claimed that Dupixent will be nation's first biologic medicine approved for these conditions.
Skip to content